Actavis is a member of the Teva Group, one of the largest pharmaceutical companies in the world. Our fundamental goal is to improve the quality of life and protect health with high-quality and more affordable medicines. We continuously provide the health system and patients with a wide range of therapies for almost all therapeutic areas.
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a leading global pharmaceutical company providing first-class healthcare solutions dedicated to the millions of patients who use them every day. Based in Israel, Teva is the largest manufacturer of generic drugs in the world, with a strong portfolio of over 1,800 molecules for the production of a wide range of generic products in almost every one of the therapeutic areas. In the field of specialized drugs, Teva has a world-leading position in the innovative therapy of central nervous system disorders, including pain, as well as a strong portfolio of respiratory products. Teva integrates its capabilities in the generic and specialized pharmaceutical industries within its global R&D sector to create new approaches to meeting the open needs of patients through a combination of drug and medical device development capabilities, services and technologies.